Agreed Figgs. This is very much a binary event.
Post# of 148183
If we show statistically significant reduction in mortality, we will get an EUA quickly and eventually a full approval. Depending on how long this pandemic lasts, will dictate how much Vyrologix we produce and sell. (and how high the share price goes).
If we fail in COVID, the share price will take a hit until we are able to get HIV approved.
What's interesting about THIS binary event, and the future of Vyrologix, is that while this is a binary event, it is by no means the only event. We have many potential indications, we just need some revenue to push them all forward.